A predictive model for endometriosis

Human Reproduction

Volumn 20, Issue 6, 2005, Pages 1702-1708

  Wolfler M M ^a,c   Nagele, F ^a   Kolbus, A ^a   Seidl, S ^a   Schneider, B ^b   Huber, J C ^a   Tschugguel, Walter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Aromatase; Endometriosis; Endometrium; Menstrual characteristics; Predictive model

Indexed keywords

ANDROGEN; AROMATASE; MESSENGER RNA;

ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSMENORRHEA; ENDOMETRIOSIS; ENDOMETRIUM BIOPSY; ESTROGEN SYNTHESIS; FEMALE; FISHER EXACT TEST; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; PREDICTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STUDENT T TEST; WESTERN BLOTTING;

EID: 20744441224     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh796     Document Type: Article

References (41)

1. Abbott JA, Hawe J, Clayton RD and Garry R (2003) The effects and effectiveness of laparoscopic excision of endometriosis: a prospective study with 2-5 year follow-up. Hum Reprod 18,1992-1997.
2. American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine classification of endometriosis. Fertil Steril,817-821.
3. Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE and Spandidos DA (2003) CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril 1,702-709.
4. Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR and Agarwal A (2002) Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 17, 426-431.
5. Bergqvist A, Bruse C, Carlberg M and Carlstrom K (2001) Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril 75,489-495.
6. Brosens I (1997) Diagnosis of endometriosis. Semin Reprod Endocrinol 15, 229-233.
7. Brosens I, Puttemans P, Campo R, Gordts S and Brosens J (2003) Non-invasive methods of diagnosis of endometriosis. Curr Opin Obstet Gynecol 15,519-522.
8. Brosens J, Verhoeven H, Campo R, Gianaroli L, Gordts S, Hazekamp J, Hagglund L, Mardesic T, Varila E, Zech J and Brosens I (2004) High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 19,352-356.
9. Bulun SE, Noble LS, Takayama K, Michael MD, Agarwal V, Fisher C, Zhao Y, Hinshelwood MM, Ito Y and Simpson ER (1997) Endocrine disorders associated with inappropriately high aromatase expression. J Steroid Biochem Mol Biol 61,133-139.
10. Bulun SE, Gurates B, Fang Z, Tamura M, Sebastian S, Zhou J, Amin S and Yang S (2002) Mechanisms of excessive estrogen formation in endometriosis. J Reprod Immunol 55,21-33.
11. Chapron C, Fauconnier A, Dubuisson JB, Barakat H, Vieira M and Breart G (2003) Deep infiltrating endometriosis: relation between severity of dysmenorrhoea and extent of disease. Hum Reprod 18,760-766.
12. Cramer DW, Wilson E, Stillman RJ, Berger MJ, Belisle S, Schiff I, Albrecht B, Gibson M, Stadel BV and Schoenbaum SC (1986) The relation of endometriosis to menstrual characteristics, smoking, and exercise. J Am Med Assoc 255,1904-1908.
13. Darrow SL, Vena JE, Batt RE, Zielezny MA, Michalek AM and Selman S (1993) Menstrual cycle characteristics and the risk of endometriosis. Epidemiology 4,135-142.
14. Dheenadayalu K, Mak I, Gordts S, Campo R, Higham J, Puttemans P, White J, Christian M, Fusi L and Brosens J (2002) Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis. Fertil Steril 78,825-829.
15. Donnez J, Pirard C, Smets M, Jadoul P and Squifflet J (2003) Pre- and post- surgical management of endometriosis. Semin Reprod Med 21,235-242.
16. Eskenazi B, Warner M, Bonsignore L, Olive D, Samuels S and Vercellini P (2001) Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril 76,929-935.
17. Falcone T and Mascha E (2003) The elusive diagnostic test for endometriosis. Fertil Steril 80,886-888.
18. Fang Z, Yang S, Gurates B, Tamura M, Simpson E, Evans D and Bulun SE (2002) Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab 87,3460-3466.
19. Gagne D, Rivard M, Page M, Lepine M, Platon C, Shazand K, Hugo P and Gosselin D (2003) Development of a nonsurgical diagnostic tool for endometriosis based on the detection of endometrial leukocyte subsets and serum CA-125 levels. Fertil Steril 80,876-885.
20. Halme J, Hammond MG, Hulka JF, Raj SG and Talbert LM (1984) Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 64,151-154.
21. Harada T, Kubota T and Aso T (2002) Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis. Fertil Steril 78,733-739.
22. Ishihara H, Kitawaki J, Kado N, Koshiba H, Fushiki S and Honjo H (2003) Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 1,735-742.
23. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y and Honjo H (1997) Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 57,514-519.
24. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S and Honjo H (1999) Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 72, 1100-1106.
25. Kuohung W, Jones GL, Vitonis AF, Cramer DW, Kennedy SH, Thomas D and Hornstein MD (2002) Characteristics of patients with endometriosis in the United States and the United Kingdom. Fertil Steril 78,767-772.
26. Lebovic DI, Mueller MD and Taylor RN (2001) Immunobiology of endometriosis. Fertil Steril 75,1-10.
27. Leyendecker G, Herbertz M, Kunz G and Mall G (2002) Endometriosis results from the dislocation of basal endometrium. Hum Reprod 17, 2725-2736.
28. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25,402-408.
29. Mahmood TA and Templeton A (1991) Prevalence and genesis of endometriosis. Hum Reprod 6,544-549.
30. Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M and Sueldo C (2002) Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 77,1141-1147.
31. Noble LS, Simpson ER, Johns A and Bulun SE (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81,174-179.
32. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82,600-606.
33. Olive DL and Pritts EA (2001) Treatment of endometriosis. N Engl J Med 345,266-275.
34. Olive DL and Schwartz LB (1993) Endometriosis. N Engl J Med 328, 1759-1769.
35. Osteen KG, Bruner KL and Sharpe-Timms KL (1996) Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 14,247-255.
36. Sampson J (1927) Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol,422-429.
37. Spaczynski RZ and Duleba AJ (2003) Diagnosis of endometriosis. Semin Reprod Med 21,193-208.
38. Vessey MP, Villard-Mackintosh L and Painter R (1993) Epidemiology of endometriosis in women attending family planning clinics. Br Med J 306,182-184.
39. Walsh TM, LeBlanc L and McGrath PJ (2003) Menstrual pain intensity, coping, and disability: the role of pain catastrophizing. Pain Med 4,352-361.
40. Zeitoun KM and Bulun SE (1999) Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 72, 961-969.
41. Zeitoun K, Takayama K, Sasano H, Suzuki T, Moghrabi N, Andersson S, Johns A, Meng L, Putman M, Carr B and Bulun SE (1998) Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83, 4474-4480.